Inventories - Additional Information (Detail) - USD ($) $ in Thousands |
Nov. 30, 2020 |
May 31, 2020 |
---|---|---|
Inventory [Line Items] | ||
Inventories | $ 99,071 | $ 19,147 |
Work in progress bulk drug substance | 70,777 | |
Bulk Drug Substance [Member] | ||
Inventory [Line Items] | ||
Work in progress bulk drug substance | 41,100 | |
Drug Products [Member] | ||
Inventory [Line Items] | ||
Work in progress bulk drug substance | $ 29,700 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|